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Interstrand cross-links (ICLs) are an extremely toxic class of DNA damage incurred during normal metab-
olism or cancer chemotherapy. ICLs covalently tether both strands of duplex DNA, preventing the strand
unwinding that is essential for polymerase access. The mechanism of ICL repair in mammalian cells is poorly
understood. However, genetic data implicate the Ercc1-Xpf endonuclease and proteins required for homolo-
gous recombination-mediated double-strand break (DSB) repair. To examine the role of Ercc1-Xpf in ICL
repair, we monitored the phosphorylation of histone variant H2AX (-H2AX). The phosphoprotein accumu-
lates at DSBs, forming foci that can be detected by immunostaining. Treatment of wild-type cells with
mitomycin C (MMC) induced -H2AX foci and increased the amount of DSBs detected by pulsed-field gel
electrophoresis. Surprisingly, -H2AX foci were also induced in Ercc1/ cells by MMC treatment. Thus, DSBs
occur after cross-link damage via an Ercc1-independent mechanism. Instead, ICL-induced DSB formation
required cell cycle progression into S phase, suggesting that DSBs are an intermediate of ICL repair that form
during DNA replication. In Ercc1/ cells, MMC-induced -H2AX foci persisted at least 48 h longer than in
wild-type cells, demonstrating that Ercc1 is required for the resolution of cross-link-induced DSBs. MMC
triggered sister chromatid exchanges in wild-type cells but chromatid fusions in Ercc1/ and Xpf mutant cells,
indicating that in their absence, repair of DSBs is prevented. Collectively, these data support a role for
Ercc1-Xpf in processing ICL-induced DSBs so that these cytotoxic intermediates can be repaired by homol-
ogous recombination.
Interstrand cross-links (ICLs) comprise a unique class of
DNA lesions that have a potent biological effect. By definition,
ICLs involve covalent modification of both strands of DNA.
Therefore, these adducts prevent DNA strand separation and
block DNA metabolism, such as transcription and replication
(31). DNA-damaging agents that cause ICLs are extremely
cytotoxic, and their utility as anticancer chemotherapeutics
likely stems from their selective toxicity to proliferating cells.
ICLs occur via a two-step reaction mechanism in which first a
monoadduct involving one strand of DNA is formed (24).
Although cross-linking agents induce a variety of DNA ad-
ducts, the relative cytotoxicity of each agent correlates with its
ability to form ICLs (43, 44).
The repair of DNA ICLs presents a unique challenge to
cells. Since both strands of DNA are covalently modified, sim-
ple excision of the lesion followed by template-driven DNA
resynthesis is precluded. In Escherichia coli, two solutions to
this problem have been identified (reviewed in reference 19).
In both these repair mechanisms, the ICL is excised from one
strand. In error-free repair, an undamaged chromosome is
then utilized as a template for gap-filling DNA polymerization
(55). ICL repair also occurs in recombination-deficient E. coli,
likely via translesional DNA polymerization of the second
damaged strand (5). Similarly, genetic analysis of Saccharomy-
ces cerevisiae (23) and mammalian DNA repair mutants (re-
viewed in reference 19) indicates the involvement of proteins
from multiple DNA repair pathways in ICL repair: nucleotide
excision repair (NER), homologous recombination, and pos-
treplication repair.
An interesting difference in ICL repair between S. cerevisiae
and higher eukaryotes is that in mammals, not all NER mu-
tants are equally sensitive to ICLs (19). Xpf and Ercc1 mutants
are much more sensitive than Xpa mutants. In cells, the Xpf
and Ercc1 proteins heterodimerize (7, 59) to form a structure-
specific endonuclease that nicks double-stranded DNA adja-
cent to a 3 single-strand region (4). Ercc1-Xpf is responsible
for incising the damaged strand of duplex DNA 5 to a lesion
in NER of monoadducts (41, 54). A second endonuclease with
opposite polarity (Xpg) is required for complete excision of a
damaged oligonucleotide during NER (35). Furthermore, Xpa
is required to recruit Ercc1-Xpf to the site of DNA damage
(60), and the presence of Xpg is required for Ercc1-Xpf cata-
lytic activity in NER (61), yet neither Xpa nor Xpg mutants are
as sensitive to ICL damage as Xpf and Ercc1 mutants (17).
Thus, ICL repair is distinct from NER in eukaryotes, and
complete removal of an ICL likely necessitates a second nu-
clease, in addition to Ercc1-Xpf, that can incise 3 to the lesion.
Also in contrast to prokaryotes, there is evidence in eu-
karyotes that ICLs elicit double-strand breaks (DSBs) (9, 12,
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17, 33, 37). Thus, it has been proposed that in mammalian cells
ICL repair proceeds via the formation of a DSB, with subse-
quent repair of the DSB occurring by homologous recombina-
tion (6, 17, 29). Such models are consistent with the fact that
cells deficient in Rad51 paralogues or other proteins involved
in homologous recombination-mediated DSB repair are sensi-
tive to agents that induce DNA ICLs (17, 19). In addition,
there is evidence that Ercc1-Xpf participates in certain homol-
ogous recombination pathways in eukaryotes (27, 42, 51–53).
In Saccharomyces cerevisiae, rad1 and rad10 are epistatic in
relation to mitotic recombination (53), suggesting that het-
erodimerization and therefore likely endonuclease activity are
required for recombination. Indeed, Rad1-Rad10 cleaves non-
homologous single-strand ends from DSBs to facilitate repair
via homologous recombination in S. cerevisiae (21, 45), as do
the hamster homologues (1).
In this study, we investigated the role of Ercc1-Xpf in DNA
ICL repair by using immunodetection of histone variant
-H2AX to visualize DSBs in the nuclei of cells (47). H2AX is
a histone that is specifically phosphorylated at Ser139 upon
DSB induction (40, 48). This modification accumulates at sites
of DNA DSBs, yielding discrete foci at breaks detected by
immunostaining with an antibody against the phosphoepitope
(47). Our results reveal that Ercc1-Xpf is not required for the
formation of DSBs after cross-link damage but is imperative
for their resolution.
MATERIALS AND METHODS
Cell lines. The generation, characterization, and culturing of Ercc1/ embry-
onic stem (ES) cells have been described previously (42). Primary mouse em-
bryonic fibroblast (MEF) lines were developed from day 13.5 embryos from
either Ercc1/ or Xpa/ crossings as described previously (64). The genetic
background was either C57BL/6 or FVB/n. Genomic DNA was isolated from a
tissue sample of each embryo after overnight digestion with proteinase K in 50
mM Tris-HCl (pH 7.5)–100 mM EDTA–100 mM NaCl–1% sodium dodecyl
sulfate. Genotyping of the Ercc1 allele was done by PCR coamplification of
intron 7 from the wild-type allele and the 3 end of the selectable neomycin
resistance marker from the targeted allele with a combination of primers specific
for exons 7 and 8 of Ercc1 and neor (5-GAAAAGCTGGAGCAGAACTT,
5-AGATTTCACGGTGGTCAGAC, and 5-GAAGAGCTTGGCGGCGA
ATG, respectively) (64). Genotyping of the Xpa allele was also done by PCR
(18). MEFs were cultured in a 1:1 mix of Dulbecco’s modified Eagle’s medium
and Ham’s F10 with 10% fetal calf serum and antibiotics. Each experimental
replica was done with a new MEF line, created from a unique embryo, in its
second or third passage. Cell lines derived from wild-type littermates were used
as controls in all experiments.
Immunofluorescence. Cells were trypsinized and seeded at approximately 25%
confluence on glass coverslips. For ES cells, the glass was coated with gelatin.
Sixteen hours later, the cells were irradiated with  rays (10 Gy) or UV-C (254
nm, 10 J/m2). For other experiments, the wild-type and mutant cells were ex-
posed for 1 h to equitoxic doses of mitomycin C (MMC) or cisplatin, with doses
giving 10% survival. For MEFs, the concentrations were 3 and 1 M MMC for
wild-type and mutant cells, respectively. For ES cells, 3 M and 300 nM MMC
were used. For exposure of ES cells to cisplatin, 13.3 and 3.3 M concentrations
of the drug were used for wild-type and Ercc1-deficient cells, respectively. Af-
terwards, the cells were washed and incubated in fresh medium at 37°C for the
indicated amount of time and then fixed with 2% paraformaldehyde in sodium
phosphate buffer, pH 7.4, for 15 min. Cells were permeabilized with 0.1% Triton
X-100 in phosphate-buffered saline, and the phosphorylated form of H2AX
(-H2AX) was detected with polyclonal anti--H2AX (1:1,000; Upstate Biotech-
nologies) and Alexa 488-conjugated goat anti-rabbit immunoglobulin (1:500;
Molecular Probes) in phosphate-buffered saline with 0.15% glycine and 0.5%
bovine serum albumin. Nuclear staining patterns were visualized with a Leica
DMRB fluorescent microscope and fluorescein isothiocyanate filter at 40 to
100 magnification. For cell cycle arrest in G1, cells were treated with DNA-
damaging agents 48 h after reaching confluence. Duplicate plates of the cells
were subsequently released from arrest by trypsinization and reseeding on cov-
erslips at low cell density.
Detection of DSBs by pulsed-field gel electrophoresis. Subconfluent cultures of
wild-type and Ercc1/ ES cells were treated with 7.2 M MMC for 1 h.
Afterwards, the cells were washed extensively with phosphate-buffered saline and
incubated with fresh medium for 6 to 48 h. Cells were harvested by trypsinization,
and agarose plugs of 5  106 cells were prepared with a CHEF disposable plug
Mold (Bio-Rad). The samples were lysed with proteinase K (1 mg/ml in100 mM
EDTA–0.2% sodium deoxycholate–1% sodium lauryl sarcosine) for 48 h at 50°C
and then washed repetitively with Tris-EDTA. The plugs were electrophoresed
for 23 h at 13°C in 0.9% agarose and 250 mM Tris-borate-EDTA with a Biometra
Rotaphor apparatus with the following parameters: interval, 30 to 5 s log; angle,
120 to 110° linear; 180 to 120 V log). The gels were stained with ethidium
bromide for 5 h and then destained for 16 h in 250 mM Tris-borate-EDTA, and
the DNA was visualized with a Typhoon 9200 scanner (Amersham Pharmacia
Biotech).
Flow cytometric analysis. Subconfluent cultures of early-passage primary
MEFs or ES cells were exposed for 1 h to equitoxic concentrations of MMC as
indicated above. The cells were then washed and grown for an additional 12 h,
at which point they were harvested by trypsinization, fixed in 70% ethanol, and
stained with propidium iodide. The DNA content of the cells was determined by
fluorescence-activated cell sorting (FACS) using a Facscan (Becton Dickinson).
The fraction of cells in each phase of the cell cycle was calculated with CellQuest.
Chromosome and sister chromatid exchange analysis. Wild-type (CHO9 and
AA8) and mutant (CHO43-3B for Ercc1 and UV47 for Xpf) Chinese hamster
ovary (CHO) and murine ES cells were exposed for 1 h to equitoxic doses of
cisplatin or MMC corresponding to 10% survival and then washed, and the
medium was exchanged for one containing bromodeoxyuridine (BrdU; 10 g/
ml). Cultures were grown for an additional 24 h, and the cells were harvested by
trypsinization and prepared for metaphase analysis as previously described (20).
Nuclei were scored as being in either the first or second metaphase division,
based on the differential staining pattern of sister chromatids with acridine
orange as a fluorescent stain. The number of aberrations per metaphase was
counted, and the aberrations were classified as chromatid type, chromosome
aberrations, or structures resulting from fusions.
RESULTS
Detection of DSBs after DNA damage. To determine if pro-
cessing of DNA ICLs causes genomic DSBs, proliferating cul-
tures of wild-type primary MEFs were plated on glass cover-
slips, exposed to various DNA-damaging agents, and then fixed
and stained for the phosphoepitope of H2AX (-H2AX). Un-
treated cells displayed a homogenous nuclear staining, with a
fraction of cells containing either one or two foci or 10 foci
(Fig. 1A, first panel). As expected, when DSBs were induced
with -irradiation, the -H2AX staining revealed a punctate
pattern of 10 foci in virtually every nucleus (Fig. 1A, middle
panel) (47). Foci of -H2AX were also induced in the majority
of cells by MMC, a DNA ICL-inducing agent (Fig. 1A, last
panel), demonstrating that DSBs are indeed a consequence of
ICL damage. These data support previous reports of ICL-
dependent DSBs in yeast and mammalian cells detected by
alkaline elution (9, 33) and pulsed-field gel electrophoresis (12,
13, 17, 37).
At the concentration of MMC used (3 M), the number of
ICLs is approximated to be on the order of 103 per genome
(44, 63). However, the maximum number of foci detected was
two orders of magnitude lower, reflecting either an inefficient
yield of DSBs from ICLs or the relatively low resolution of this
technique (47). -H2AX foci were also observed in wild-type
ES cells treated with MMC (Fig. 1B). Thus, DSB formation is
not a cell type-specific event. In contrast to MMC, UV-C
irradiation, which causes intrastrand cross-links, did not elicit
the formation of prominent -H2AX foci at the dose used (Fig.
1B) (46). We conclude that DSB formation is a specific con-
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sequence of processing DNA ICLs but not intrastrand cross-
links.
Quantitation of DSBs after cross-link damage. To quanti-
tate DSB formation after MMC treatment, the number of
-H2AX foci in each cell was counted and the cells were
categorized as having zero, one to two, or more than two foci
per nucleus. Spontaneous foci were detected in 30% of wild-
type MEFs (Fig. 1C and D). Half of these cells had only one to
two foci each, likely reflecting unrepaired, spontaneous DNA
damage. The other half of the cells had an average of 10
-H2AX foci. These are likely cells that were in, or recently
emerged from, S phase at the time of fixation (22, 39, 46, 47).
Accordingly, the fraction of cells with more than two sponta-
neous foci approximates the fraction of primary MEFs that
were not in the G1 phase of the cell cycle in an unsynchronized
culture (see Fig. 3) (28).
At the lowest dose of MMC tested (0.6 M), there was a
20% decrease in the number of fibroblasts with no -H2AX
foci, while the fraction of cells with either one to two or more
than two foci increased proportionally (Fig. 1C). At higher
concentrations of MMC, not only did the percentage of cells
with foci continue to increase, but the number of foci per
nucleus also increased, so that the fraction of cells with more
than two foci exceeded the fraction of cells with only one to
FIG. 1. -H2AX foci in wild-type cells after DNA damage. (A) Early-passage wild-type (wt) primary MEFs were seeded on glass coverslips at
low cell density. After 16 h, the cells were exposed to 10 Gy of -irradiation or to 3 M MMC for 1 h and then further incubated at 37°C. Ten
hours later, the cells were fixed and immunostained for -H2AX. (B) Wild-type murine ES cells were seeded on gelatin-coated glass coverslips and
after 16 h exposed to UV-C (254 nm, 10 J/m2) or 3 M MMC for 1 h. The cells were cultured for an additional 14 h and then fixed and processed
as described for panel A. (C) Quantitation of -H2AX foci after exposure of cells to increasing concentrations of MMC. Early-passage wild-type
primary MEFs seeded on glass coverslips were exposed to a range of concentrations of MMC for 1 h and then grown in fresh medium for 12 h
prior to fixation and immunostaining for -H2AX. For each data point, more than 100 nuclei were examined, the -H2AX foci were counted, and
the cells were categorized as having zero, one to two, or more than two foci per nucleus. The percentage of cells in each category is plotted.
(D) Quantitation of -H2AX focus formation at various time points after exposure of wild-type cells to 3 M MMC. Error bars indicate the
standard error of the mean when the data were collected from more than three individual experiments.
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two foci. Thus, DSB formation after ICL damage is dose de-
pendent. At MMC concentrations above 3 M, there was no
further increase in the fraction of cells with foci. The observa-
tion that only 60% of an unsynchronized population of fi-
broblasts responded to MMC-induced damage within a 12-h
period provides an indication that DSB formation might re-
quire cell cycle progression.
The time course of -H2AX focus formation further sup-
ports this conclusion (Fig. 1D). We detected no appreciable
increase in the fraction of cells with foci until 6 h after expo-
sure to the saturating dose of MMC (3 M; data not shown).
At 12 h, the fraction of cells with foci peaked and subsequently
declined, most likely due to DSB repair. This is in striking
contrast to the kinetics of -irradiation-induced -H2AX focus
formation and resolution. -Irradiation inflicts DSBs directly,
and -H2AX foci are detected immediately. Their number
peaks within minutes of irradiation and begins to decline
within 15 min (47). Thus, DSB formation after cross-link dam-
age is clearly indirect and possibly linked to cell cycle progres-
sion.
Detection of DSBs after DNA damage of Ercc1/ cells. To
determine if Ercc1-Xpf endonuclease is required for the cre-
ation of ICL-dependent DSBs, we investigated whether
-H2AX foci would form in Ercc1-deficient cells after expo-
sure to various ICL-inducing agents. In contrast to wild-type
cells, analysis of untreated Ercc1/ primary MEFs revealed a
high frequency of nuclei with one to two spontaneous -H2AX
foci (Fig. 2A, first panel), suggesting a higher steady-state level
of unrepaired DNA damage in the mutant cells. As in wild-
type cells, -irradiation induced a dramatic increase in the
number of -H2AX foci (Fig. 2A, middle panel). MMC also
induced -H2AX focus formation in the Ercc1/ MEFs (Fig.
2A, last panel). As with the wild-type cells, the response to
MMC was not cell type specific but was specific for agents that
cause DNA ICLs (Fig. 2B). Large numbers of -H2AX foci
were induced not only by MMC but also by cisplatin, indicating
that DSB formation is also not peculiar to a specific cross-
linking agent. As in the mutant MEFs, Ercc1/ ES cells had
an increased incidence of spontaneous -H2AX foci compared
to wild-type ES cells (Fig. 2B versus 1B), suggesting genomic
instability or persistent endogenous DNA damage as a result of
a mutation in Ercc1. We conclude that the formation of ICL-
induced DSBs is Ercc1 independent.
Kinetics of -H2AX focus formation in Ercc1/ MEFs. The
number of -H2AX foci in Ercc1/ MEFs after exposure to
MMC at a concentration equitoxic to that used for wild-type
cells was counted. Quantitation of foci in untreated Ercc1/
cells revealed a significantly greater fraction of cells with one to
two foci (35	 5%) than in untreated wild-type cells (16	 6%;
Fig. 2C versus 1D), indicating a higher steady-state level of
DSBs in the mutant cells. As in wild-type cells, by 12 h after
exposure to MMC, the fraction of cells with more than two foci
dominated. The peak percentage of Ercc1/ cells with more
than two foci approximated that of wild-type cells after expo-
sure to MMC. Thus, the formation of DSBs in response to ICL
damage is identical in wild-type and Ercc1/ MEFs. Interest-
ingly, once the MMC-induced -H2AX foci appeared in
Ercc1/ cells, they persisted (Fig. 2C). Up to 72 h after the
induction of ICL damage, the percentage of cells with more
than two foci remained elevated, whereas in wild-type cells, the
fraction of nuclei with more than two foci began to decline
within 12 h of reaching its zenith (Fig. 1D).
To confirm that the persistent -H2AX foci in the Ercc1/
cells reflected DSBs, we analyzed genomic DNA from MMC-
treated cells by pulsed-field gel electrophoresis (Fig. 2E). In-
creased amounts of lower-molecular-weight DNA were de-
tected in wild-type and Ercc1/ cell plugs beginning 6 h after
MMC treatment, confirming that the accumulation of -H2AX
foci coincides with the creation of DSBs. Analogous to the
immunofluorescence results, the amount of DSBs detected by
pulsed-field gel electrophoresis at 24 to 48 h after MMC treat-
ment was substantially greater in Ercc1/ cells than in wild-
type cells. Together, these data demonstrate that DSBs are
indeed an intermediate of cross-link repair and that Ercc1 is
required for the resolution of ICL-induced DSBs.
To determine if this function was unique to Ercc1 or related
to its role in NER, we repeated the immunofluorescence assay
with Xpa/ primary MEFs. In these NER-deficient cells, as in
wild-type cells, the fraction of cells with more than two foci
declined significantly within 36 h of reaching a maximum (Fig.
2D). These data demonstrate that Ercc1, but not NER, is
required for the resolution of ICL-induced DSBs.
Cell cycle dependence of -H2AX focus formation. Since
Ercc1-Xpf endonuclease is not required for the formation of
DSBs after induction of ICLs, we sought to determine how
these DSBs do occur. To test the possibility that DNA repli-
cation was involved, we looked for -H2AX focus formation in
nonproliferating cells. Wild-type primary MEFs were seeded
at a high cell density to arrest them in G1 by contact inhibition.
Under these conditions, MMC-induced -H2AX focus forma-
tion was significantly attenuated compared to that in asynchro-
nous cells (Fig. 3A versus 1D). The fraction of cells without
foci remained stable for 48 h after exposure to MMC. How-
ever, when we exposed nonproliferating cells to MMC, incu-
bated them for 12 h, and then trypsinized and reseeded them
at a low cell density to release their cell cycle block, -H2AX
foci appeared (Fig. 3B). The fraction of cells with more than
two foci was elevated at 9 and 12 h after trypsinization and then
diminished by 36 h after release from cell cycle arrest. Thus,
ICL-induced DSBs are only seen in actively cycling cells.
Cell cycle arrest by cross-link damage. Next we examined
the impact of ICL damage on the cell cycle of primary MEFs
and ES cells. Proliferating wild-type and Ercc1/ cells were
treated with equitoxic concentrations of MMC and then cul-
tured for an additional 12 h, at which point the greatest num-
ber of cells have DSBs. The cells were analyzed for DNA
content by FACS, and the percentage of cells in the various
stages of the cell cycle was plotted (Fig. 3C to E). MMC
induced a strong arrest in late S/G2/M of the cell cycle in
wild-type ES cells (Fig. 3C). This arrest was even more pro-
found in Ercc1/ ES cells treated with MMC (Fig. 3D). Thus,
the time point at which DSB incidence is maximal (12 h post-
MMC treatment) coincides with a profound late S/G2/M cell
cycle arrest, strongly implicating S-phase DNA replication in
the creation of DSBs. The arrest in primary MEFs was much
less dramatic (Fig. 3E), which is not surprising in that the
proliferation rate of primary MEFs is about half that of ES
cells.
Chromosomal aberrations induced by ICL damage. We
sought to determine the consequence of ICLs at the chromo-
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FIG. 2. -H2AX foci in Ercc1/ cells after DNA damage. (A) Early-passage Ercc1/ primary MEFs were seeded on glass as described for
Fig. 1. DNA damage was induced with 10 Gy of -irradiation (equivalent dose to wild-type cells) or 1 M MMC (equitoxic to wild-type cells) for
1 h. (B) Ercc1/ ES cells were seeded on glass as described for Fig. 1. DNA damage was induced with UV-C at 10 J/m2 (equivalent dose to
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some level. Proliferating wild-type and Ercc1/ ES cells were
exposed to equitoxic concentrations of MMC for 1 h, and
subsequently the medium was exchanged for one containing
BrdU. After 24 h, the cells were harvested, and metaphase
spreads were prepared. By examining the differential staining
patterns of sister chromatids, the fraction of cells that had gone
through either one or two S phases since the MMC treatment
was determined. All of the metaphases from wild-type cells,
with or without MMC exposure, had a staining pattern indic-
ative of two rounds of replication in the presence of BrdU (Fig.
4A and Table 1). Chromosomal aberrations were rare and
never complex. MMC induced an increased incidence of sister
chromatid exchanges.
In contrast, in spreads prepared from Ercc1/ ES cells
treated with MMC, anaphase bridging and micronuclei were
common (Fig. 4C), indicating chromatid nondisjunction. Only
half of the Ercc1/ cells exposed to MMC had reached the
second division, demonstrating that the cell cycle delay in the
mutant cells is substantially longer than in wild-type cells (Ta-
ble 1). Furthermore, the metaphase spreads revealed a com-
plex constellation of aberrations in response to MMC (Fig. 4B
and Table 1). All metaphases arrested in the first division
displayed numerous breaks, radial structures, and fusions. In-
terestingly, the majority of aberrations observed in wild-type
and mutant cells were of the chromatid type, indicating that
that their inception occurs during the previous S phase. None
of the fusions observed were end to end, which was confirmed
by detecting a full complementation of telomeres (n 
 40) by
fluorescent in situ hybridization with a telomere-specific probe
(data not shown). Instead, all of the fusions were within the
chromosomes, indicating the sites of unrepaired DSBs created
during attempted replication of ICLs.
The same pattern of cell cycle arrest and chromosomal ab-
errations was observed with wild-type and Ercc1 mutant CHO
cells treated with cisplatin, reinforcing the idea that the ob-
served results are neither cell type nor cross-linking agent
specific (Fig. 4E, F, and G and Table 1). Furthermore, an Xpf
mutant CHO cell line was studied, and it behaved identically to
Ercc1-deficient cell lines (Fig. 4E and Table 1), extending
these observations to both components of the Ercc1-Xpf en-
donuclease complex.
DISCUSSION
ICL-induced DSB formation is Ercc1 independent. To in-
vestigate the mechanism of DNA ICL repair in mammalian
cells and to elucidate the role of the endonuclease Ercc1-Xpf,
we studied the formation of DSBs in wild-type and Ercc1-Xpf-
deficient cells treated with cross-linking agents by -H2AX
immunodetection. We discovered that -H2AX foci form spe-
cifically in response to damaging agents that cause DNA ICLs
and that these foci reflect genomic DSBs (Fig. 1 and 2).
-H2AX focus formation after MMC damage is dose depen-
dent and time dependent (Fig. 1C and D), strongly suggesting
that DSBs are an intermediate of ICL repair. Interestingly,
-H2AX foci also form in response to ICL damage in Ercc1-
deficient cells (Fig. 2A and B). These data demonstrate that
the endonuclease activity of Ercc1-Xpf does not participate in
the formation of ICL-induced DSBs. Our data differ from
those described in a recent report in which it was demonstrated
that Ercc1 mutant CHO cells display a decreased level of
-H2AX upon treatment with hydroxymethyl-4,5,8-trimeth-
ylpsoralen and UV-A compared to wild-type cells treated sim-
ilarly (49). This difference may stem from differential process-
ing of monoadducts and ICLs in cells with various degrees of
checkpoint response or from different methods of quantitating
-H2AX. Nevertheless, in our system, in which monoadducts
(UV-C) do not induce -H2AX foci, MMC did, even in cells in
which Ercc1 is genetically deleted.
Interestingly, in both Ercc1/ primary MEFs and ES cells,
we detected a higher frequency of spontaneous -H2AX foci
than in wild-type cells (Fig. 2C versus 1D). This is consistent
with the Ercc1-deficient cells’ being genomically unstable,
which may be a consequence of unrepaired endogenous ICLs.
Elevated levels of spontaneous -H2AX foci are also observed
in tumor cell lines (47), cell lines deficient in the DSB repair
proteins DNA-PKcs and NBS1, and cells defective in the DNA
damage-signaling molecule ATM (46).
Formation of ICL-induced DSBs requires cell cycle progres-
sion, and their repair is slow. Several observations suggest that
ICL-induced DSB formation is cell cycle dependent. First,
MMC-induced -H2AX foci did not begin to accumulate until
6 h after drug exposure (Fig. 1), which may be because MMC
must be metabolically activated (19) or ICLs form more slowly
than monoadducts (24). However, once MMC-induced
-H2AX foci began to appear in an asynchronous cell popu-
lation, an additional 6 h was required before the majority of
cells had foci (Fig. 1). Furthermore, only 60% of the cells
treated with MMC ever produced foci in the 24-h period fol-
lowing damage. In contrast, -H2AX foci appear in all cells
within minutes of -irradiation (47). Second, rapidly dividing
cells are much more sensitive to cross-linking agents than
slowly proliferating cells (25, 41, 62). Finally, ICL-induced
DSBs occur only in proliferating cultures of S. cerevisiae (37).
Similarly, in G1-arrested primary MEFs, MMC did not induce
-H2AX foci (Fig. 3A), in accordance with a recent study by
Rothfuss and Grompe with primary human fibroblasts treated
with psoralen (49). However, if the cells were released from
their cell cycle block, there was a time-dependent increase in
the fraction of cells with foci (Fig. 3B). This result demon-
strates that ICL-induced DSB formation in mammalian cells,
as in S. cerevisiae, requires cell cycle progression.
wild-type cells), 300 nM MMC, or 3.3 M cisplatin (both equitoxic doses to wild-type cells) for 1 h. (C) Quantitation of -H2AX focus formation
at various times after exposure of Ercc1/ MEFs to 1 M MMC. Error bars indicate the standard error of the mean when the data points were
collected from more than three individual experiments. (D) Quantitation of -H2AX focus formation at various times after exposure of Xpa/
MEFs to 1 M MMC. (E) Detection of DSBs by pulsed-field gel electrophoresis. Wild-type (wt) and Ercc1/ ES cells were treated for 1 h with
7.2 M MMC, washed, and incubated for 0 to 48 h more in fresh medium. Plugs of 5  106 cells were prepared for each time point and analyzed
for low-molecular-weight DNA, indicative of genomic DSBs, by electrophoresis. Schizosaccharomyces pombe chromosomes were used as molecular
size markers in lane MW.
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Primary human fibroblasts do not respond to ICL damage by
arresting until they reach S phase (2). Furthermore, a site-
specific ICL in a double-stranded oligonucleotide is sufficient
to block DNA replication and trigger the formation of a DSB
in vitro (6). Thus, it is likely that the S phase of the cell cycle
is critical for ICL recognition, initiation of repair, and forma-
tion of the DSB repair intermediate. FACS analysis of wild-
type and Ercc1/ cells 12 h after MMC exposure revealed a
strong late S/early G2 arrest (Fig. 3). Therefore, at the time
when the greatest fraction of cells had -H2AX foci, the ma-
jority of the cells are arrested with 4n DNA content. DSBs
caused by -irradiation also trigger an early G2 arrest (47).
These data support the notion that ICL-induced DSBs are
incurred during DNA replication.
A striking aspect of ICL-induced -H2AX foci is the rate at
which they are resolved. The fraction of MMC-treated cells
with a large number of foci decreased by only 10% in the 12-h
time period following peak focus induction (Fig. 1). In con-
trast, the number of -irradiation-induced -H2AX foci de-
clines within 15 min. Sixty percent of -irradiation-induced
DSBs have a half-life of minutes (45). The relatively slow
resolution of ICL-induced DSBs may reflect equilibrium be-
tween the rates of DSB formation and repair after MMC-
inflicted DNA damage. However, a more likely interpretation
is that ICL-induced DSBs are structurally different from -ir-
radiation-induced DSBs and are therefore repaired differently.
This hypothesis is consistent with genetic data, which indicate
a requirement for Ercc1-Xpf for ICL repair but not for more
generic DSB repair (10, 42).
ICL-induced DSBs are not repaired in Ercc1/ cells.
Quantitation of -H2AX foci in Ercc1/ MEFs at different
time points after MMC exposure revealed that DSBs arise in
the mutant cells with the same kinetics as in wild-type cells.
However, once formed, the DSBs are significantly longer-lived
in Ercc1-deficient cells. The fraction of cells with -H2AX foci
did not decrease in the 72-h period following MMC treatment.
Furthermore, a greater fraction of Ercc1/ cells than wild-
FIG. 3. Relationship between the cell cycle, cross-link damage, and
-H2AX focus formation. (A) -H2AX focus formation after exposure
of G1-arrested wild-type (wt) MEFs to MMC. Early-passage wild-type
MEFs were seeded on glass coverslips at a very high density in order
to arrest them by contact inhibition. Forty-eight hours later, the cells
were exposed to 3 M MMC for 1 h. At the indicated times after
exposure, cells were fixed and immunostained for -H2AX. The 12-h
sample was done in duplicate. The second replicate was trypsinized
12 h after exposure to MMC, split 1:10 to release the cells from contact
inhibition, and reseeded on glass coverslips. The cells were fixed after
replating at the times indicated and analyzed as above (B). (C) FACS
profile of wild-type ES cells before and after cross-link damage.
Genomic DNA of wild-type ES cells was stained with propidium iodide
and quantitated by FACS as described in Materials and Methods.
Untreated cells were fixed and stained directly. Treated cells were
exposed to 3 M MMC for 1 h, incubated for an additional 12 h,
harvested, fixed, and stained. The G1 (2n DNA content) and G2/M
(4n) fractions of cells are indicated above each profile. (D) Cell cycle
distribution of wild-type and Ercc1/ ES cells before and after cross-
link damage. Cells were treated as described for panel C. Equitoxic
concentrations of MMC were used (3 M for wild-type cells and 0.3
M for Ercc1/ cells). The fraction of cells in G1, S, and G2/M was
determined from the FACS profile and plotted as a percentage of the
total. (E) Cell cycle distribution of wild-type and Ercc1/ primary
fibroblasts before and after cross-link damage. Cells were treated as
described above except that the equitoxic dose of MMC used for
Ercc1/ MEFs was 1 M.
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type cells were in G2 12 h after exposure to MMC, consistent
with an accumulation of mutant cells with unrepaired DNA
damage. Thus, Ercc1 plays a role late in ICL repair, after the
DSBs are formed. Similar results were reported by de Silva et
al., who used pulsed-field gel electrophoresis to detect DSBs in
mutant CHO cells reacted with bivalent nitrogen mustards
(17). Importantly, MMC-induced -H2AX foci did not persist
in NER-deficient Xpa/ MEFs, demonstrating that this role
of Ercc1-Xpf in ICL repair is independent of NER.
DSBs mediate the toxicity of ICLs. Cells that proliferate
more rapidly in culture are more sensitive to chemicals that
induce DNA ICLs than slowly proliferating cells (CHO  ES
 primary MEF cells) (26, 42, 64). Analogously, we detected a
significant G2 arrest in rapidly growing ES cells but not in
slowly proliferating primary MEFs (Fig. 3D and E). Further-
more, cells synchronized in G2/M do not respond to ICL dam-
age (by arresting or creating DSBs) until they begin traversing
the subsequent S phase (2). These data suggest a scenario in
which ICLs are first detected during the S phase of the cell
cycle. DNA replication triggers the formation of a DSB, which
in turn leads to a cell cycle arrest that persists until DSB repair
occurs. Thus, the sensitivity of various cell types to cross-link-
ing agents can be predicted based on the extent of their cell
cycle arrest, which is in turn determined by their proliferation
rate. These data provide experimental evidence for the ratio-
nale behind the use of cross-linking agents in cancer chemo-
therapy, particularly in combination with radiotherapy, as well
as an explanation for their toxic side effects in proliferative
organs such as the bone marrow and gastrointestinal tract (25).
In addition, these data implicate DSBs as the truly toxic lesion
after ICL damage.
To explore this further, we examined metaphase spreads of
FIG. 4. Analysis of chromosomal aberrations in cells exposed to cross-link damage. Subconfluent cultures of wild-type (wt) and mutant cells
were exposed to equitoxic concentrations of MMC or cisplatin for 1 h, washed twice, and then incubated for an additional 24 h in medium
containing 10 g of BrdU per ml. Thirty minutes prior to trypsinization, colcemid was added. (A) A metaphase spread from MMC-treated
wild-type ES cells, demonstrating unequal staining of the sister chromatids, indicative of two rounds of DNA replication in the presence of BrdU.
Sister chromatid exchanges (arrow) are frequent, but other aberrations are notably absent. (B) Metaphase spread of MMC-treated Ercc1/ ES
cell. Aberrations, including gaps, breaks, and radials, were common in mutant cells. Fusions between sister chromatids (indicated with arrows) were
the most abundant aberration. (C) Spread of MMC-treated Ercc1/ ES cells, demonstrating anaphase bridging (arrowhead) and micronuclei
(asterisk), hallmarks of chromatid nondisjunction and fragmentation, respectively. Furthermore, nuclear size is highly variable, indicating
variability in nuclear DNA content. (D) A representative spread from wild-type CHO cells treated with cisplatin, demonstrating frequent sister
chromatid exchanges (arrow). (E) A metaphase spread of Xpf mutant CHO cells treated with cisplatin. Staining indicates only a single round of
replication since drug treatment, and chromatid fusions are abundant (arrows). (F) A metaphase spread from cisplatin-treated Ercc1 mutant CHO
cells, also with numerous fusions (arrows). (G) Ercc1 mutant CHO cells after cisplatin treatment, with anaphase bridging (arrow) and micronuclei
(asterisk).
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wild-type and mutant ES cells after exposure to MMC (Table
1). In the wild-type ES cells, MMC triggered a high frequency
of sister chromatid exchanges (Fig. 4). These exchanges are
caused by a DSB in a chromatid that is repaired by homolo-
gous recombination with the sister as a template for DNA
synthesis (56). Thus, sister chromatid exchanges illustrate the
creation and successful repair of DSBs caused by ICLs. Other
types of chromosomal aberrations were rare in the wild-type
ES cells (Table 1).
In contrast, all of the MMC-treated Ercc1/ ES met-
aphases from cells arrested in the first division had multiple
chromosomal breaks and aberrant structures due to chromatid
fusions (Table 1). Mutant cells that progressed to anaphase
demonstrated a high frequency of micronuclei and bridging,
also a consequence of chromosomal breaks and fusions (Fig.
4C and G). These data provide further evidence that ICL-
induced DSBs are more stable in Ercc1/ cells than in wild-
type cells, corroborating the -H2AX data. The results of the
chromosome study in ES cells were recapitulated in CHO cells
treated with cisplatin and extended to include an Xpf mutant
cell line (Table 1, Fig. 4D to G) (15). These data implicate Xpf
along with Ercc1 in the resolution of ICL-induced DSBs and
thereby likely implicate the endonuclease function of the het-
erodimer.
Since Ercc1/ ES cells are sensitive to MMC but not -ir-
radiation (14, 42) and homologous recombination leading to
sister chromatid exchange is possible in Ercc1/ ES cells (Fig.
4C) (42), we conclude that ICL-induced, but not -irradiation-
induced, DSBs are resistant to homologous recombination un-
til processed by Ercc1-Xpf. One probable difference between
-irradiation-induced and MMC-induced DSBs is that in the
latter, the ICL persists after the creation of the break. Since
the DSB is created during the S phase of the cell cycle, the only
possibility for DSB repair by homologous recombination de-
mands the creation of a joint molecule between the two re-
cently replicated DNA strands at or near the site of the DSB.
An ICL near the DSB would prevent melting of the duplex
strands and thereby prevent heteroduplex formation. We pro-
pose that Ercc1-Xpf is essential to create a nick near the ICL
to make the DNA amenable to DSB repair. In the absence of
Ercc1-Xpf, the DSB cannot be repaired by homologous recom-
bination and thus is vulnerable to fusing, which is extremely
detrimental to the cell.
Model for ICL repair. Based on these results, we propose a
model for the mechanism of DNA ICL repair in mammalian
cells that incorporates an essential role for the endonuclease
function of Ercc1-Xpf late in the repair reaction (Fig. 5). Our
data and those of others suggest that ICL repair is initiated
during DNA replication (Fig. 5A) (2; reviewed in reference
38). The ICL prevents the unwinding of the two DNA strands,
stalling the replication fork (Fig. 5B). Through the action of a
structure-specific endonuclease that is not Ercc1-Xpf but may
be Mus81, the stalled fork may be converted to a DSB (6, 8, 11,
32, 36, 62), causing the appearance of -H2AX foci. Alterna-
tively, the foci may represent collapsed replication forks. Re-
gardless, stalled replication is required to trigger subsequent
events.
Because stalling of the replication fork occurs upstream of
the ICL, the resultant DSB is insufficient to remove the dam-
age from the template DNA (Fig. 5C). The formation of a DSB
on the leading strand would, however, create a new 3 end in
the template DNA in proximity to the ICL, thereby revealing
a substrate for the structure-specific endonuclease Ercc1-Xpf
(Fig. 5D) (16). The proposed cleavage by Ercc1-Xpf releases
the ICL from one of the two template strands (Fig. 5E). A DSB
on the lagging strand (not shown) creates a 5 end near the
ICL. Although this does not create an obvious substrate for
Ercc1-Xpf, the endonuclease can nick DNA 3 to an ICL (29),
which would be required to release the ICL from one strand.
However, such an incision by Ercc1-Xpf would necessitate
single-stranded DNA around the lesion, which may occur if the
DSB serves to relieve torsional strain around the ICL.
Once the residual damage is limited to one strand of DNA,
it may be bypassed by a DNA polymerase capable of transle-
sion synthesis (Fig. 5F) (37, 66) and subsequently excised from
the template strand (Fig. 5G and H), although this is not












% of metaphases with
chromosome
aberrationsd
Wild-type ES None 59 0 0 0 0
3 M MMC 57 0 2 0 1
Ercc1/ ES None 64 0 20 0 12
300 nM MMC 114 46 60e 46e 50e
Wild-type CHO None 50 6 0 0 0
10 M cisplatin 47 13 2 13 13
Ercc1 mutant CHO None 50 10 0 0 2
1 M cisplatin 48 100 0 83 62
Xpf mutant CHO None 50 9 4 0 0
1 M cisplatin 47 100 0 92 49
a The remainder of the cells had completed a second division in the period following exposure to MMC.
b Aberrations restricted to a single chromatid, including gaps, breaks, and radial structures.
c Aberrations involving joining of two sister chromatids within a chromosome (ring structure) or different chromosomes (tri- or quadriradials).
d Aberrations involving both sister chromatids, including gaps and breaks.
e Forty-six percent of these occurred in cells arrested in the first division.
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essential for resolution of the repair intermediates. Repair of
the replication-induced DSB proceeds via homologous recom-
bination (3, 32, 50). Recombination is initiated by invasion of
the 3 end of the DSB, creating a joint molecule with the
parental duplex (Fig. 5I and J) (36). Extension of the hetero-
duplex would enable reestablishment of the replication fork
(Fig. 5K).
The proposed model is consistent with an extensive body of
FIG. 5. Model for the mechanism of DNA ICL repair in mammalian cells. The two strands of DNA and their polarity are indicated in black,
with vertical lines representing base pairs. A DNA ICL is depicted as a red line connecting the two strands. Newly replicated DNA is depicted with
arrows, and for clarity, no base pairing is indicated between the template and the newly synthesized DNA strands. (A) Repair of ICLs is initiated
during DNA replication. (B) The ICL prevents the unwinding of the two DNA strands, stalling the replication fork. (C) This leads to fork
regression and the formation of a DSB in an Ercc1-Xpf-independent manner. The DSB can be detected as a local accumulation of -H2AX by
immunostaining. (D) The formation of a DSB creates a substrate for the endonuclease Ercc1-Xpf in the template DNA by revealing a 3 end near
the ICL. (E) Ercc1-Xpf cuts with its characteristic substrate specificity (indicated by scissors). The incision releases the ICL from one of the two
DNA strands. (F) The residual DNA damage may be bypassed by a DNA polymerase capable of translesion synthesis (indicated in gold). (G) It
may be that residual ICL damage is ultimately excised from the second strand (potential cut sites are indicated with arrows). (H) The resulting
gap could be filled by the replication machinery. (I) Repair of the DSB requires resection of the broken end to reveal a 3 single-stranded overhang.
(J) This 3 end invades the template DNA to create a joint molecule. This is only possible once Ercc1-Xpf has incised the blocking ICL.
(K) Expansion of the heteroduplex could enable reestablishment of the replication fork.
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genetic data that implicate proteins involved in homologous
recombination, postreplication repair, and the Ercc1-Xpf en-
donuclease but not other NER proteins in mammalian ICL
repair (reviewed in reference 19). In this study, we investigated
ICL damage caused by MMC, which causes minimal helix
distortion (58), and cisplatin, which causes significant helical
distortion (34). Cells treated with either agent behaved iden-
tically, with -H2AX foci detected after 6 h, cell cycle arrest in
late S/G2, and accumulation of chromosomal aberrations (Fig.
2 and Table 1). Thus, there is no evidence for competing repair
reactions. Obviously, if ICLs block DNA replication, they must
also impede other DNA metabolic processes that depend upon
strand separation, particularly transcription. However, we did
not detect an increase in the number of -H2AX foci in fibro-
blasts for up to 48 h after exposure to MMC, making it highly
unlikely that interference with RNA polymerase II progression
by an ICL results in a DSB (Fig. 3A).
It is interesting to speculate that the recombination-inde-
pendent and mutation-prone processing of ICLs detected by
Zheng et al. in a plasmid-based assay reflects transcription-
coupled ICL repair (66). If this is the case, it leads to the
prediction that resting cells accumulate point mutations,
whereas proliferating cells accumulate chromosomal aberra-
tions as a consequence of ICLs, both of which are observed in
vivo as a consequence of ICL damage (30, 57, 65).
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